Anti-Plasminogen Activator Inhibitor-1 | Host: Mouse | | Isotype: IgG1 | | Immunogen: partially purified human PAI-1 from conditioned medium of dexamethasone-treated HT1080 cells | | Form: Lyophilized | | Formulation: Lyophilized from a volatile buffer, 100 µg BSA. | | Preservative: None | | Positive Control: Conditioned media from dexamethasone-treated HT-1080 cells | | Comments: Recognizes the latent form of the ~50 kDa PAI-1 protein in conditioned media from dexamethasone-treated HT-1080 cells. Sold under license of U.S. Patent 5,422,245. | | Ref.: Janicke, F., et al. 1994. Cancer Research. 54, 2527. Lawrence, D. A., et al. 1994. J. Biol. Chem. 269, 15223. Nagayama, M., et al. 1994. Cancer 73, 1398. Petersen, H., et al. 1994. Cancer Res. 54, 120. Keijer, J., et al. 1991. Blood 78, 401. Blasi, F. and Verde, P., 1990. in Seminars in Cancer Biol. Vol. 1, 153. Declerck, P. J. and Collen, D., 1990. Thrombosis Res. Supplement X 3. | | Sold under license of U.S. Patent 5,422,245. | |